(Q37864901)
Statements
1 reference
Bevacizumab for the first-line treatment of human epidermal growth factor receptor 2-negative advanced breast cancer (English)
1 reference
Margarida Damasceno
1 reference
1 April 2011
1 reference
1 reference
23 Suppl
1 reference
S3-9
1 reference
Identifiers
1 reference
1 reference